142 related articles for article (PubMed ID: 3475513)
21. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
[TBL] [Abstract][Full Text] [Related]
22. Self-renewal inhibition of acute myeloid leukemia clonogenic cells by biological inducers of differentiation.
Ferrero D; Carlesso N; Pregno P; Gallo E; Pileri A
Leukemia; 1992 Feb; 6(2):100-6. PubMed ID: 1372669
[TBL] [Abstract][Full Text] [Related]
23. Effect of human recombinant granulocyte/macrophage colony-stimulating factor and native granulocyte colony-stimulating factor on clonogenic leukemic blast cells.
Asano Y; Shibuya T; Okamura S; Yamaga S; Otsuka T; Niho Y
Cancer Res; 1987 Nov; 47(21):5647-8. PubMed ID: 3499216
[TBL] [Abstract][Full Text] [Related]
24. AML bearing the translocation t(11;17)(q23;q21): involvement of MLL and a region close to RARA, with no differentiation response to retinoic acid.
Classen CF; Teigler-Schlegel A; Röttgers S; Reinhardt D; Döhner K; Debatin KM
Ann Hematol; 2005 Nov; 84(12):774-80. PubMed ID: 16044313
[TBL] [Abstract][Full Text] [Related]
25. Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation.
Prus E; Fibach E
Leuk Lymphoma; 2003 Apr; 44(4):691-8. PubMed ID: 12769347
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-4 as a growth regulator of clonogenic cells in acute myelogenous leukemia in suspension culture.
Miyauchi J; Clark SC; Tsunematsu Y; Shimizu K; Park JW; Ogawa T; Toyama K
Leukemia; 1991 Feb; 5(2):108-15. PubMed ID: 1708433
[TBL] [Abstract][Full Text] [Related]
27. PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3.
Testa U; Grignani F; Barberi T; Fagioli M; Masciulli R; Ferrucci PF; Seripa D; Camagna A; Alcalay M; Pelicci PG
Cancer Res; 1994 Aug; 54(16):4508-15. PubMed ID: 7519122
[TBL] [Abstract][Full Text] [Related]
28. cis-Retinoic acid stimulates the clonal growth of some myeloid leukemia cells in vitro.
Lawrence HJ; Conner K; Kelly MA; Haussler MR; Wallace P; Bagby GC
Blood; 1987 Jan; 69(1):302-7. PubMed ID: 3024759
[TBL] [Abstract][Full Text] [Related]
29. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
30. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3.
Hu ZB; Ma W; Zaborski M; MacLeod R; Quentmeier H; Drexler HG
Leukemia; 1996 Jun; 10(6):1025-40. PubMed ID: 8667638
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells.
Nishioka C; Ikezoe T; Yang J; Gery S; Koeffler HP; Yokoyama A
Int J Cancer; 2009 Oct; 125(7):1710-20. PubMed ID: 19507250
[TBL] [Abstract][Full Text] [Related]
32. Interactions between retinoic acid and colony-stimulating factors affecting the blast cells of acute myeloblastic leukemia.
Tohda S; Minden MD; McCulloch EA
Leukemia; 1991 Nov; 5(11):951-7. PubMed ID: 1961035
[TBL] [Abstract][Full Text] [Related]
33. Interaction of 2-chlorodeoxyadenosine in combination either with interferons or recombinant human tumor necrosis factor alpha on myeloid progenitor cells in vitro.
Korycka A; Robak T
Arch Immunol Ther Exp (Warsz); 1996; 44(4):259-64. PubMed ID: 9017167
[TBL] [Abstract][Full Text] [Related]
34. Synergistic effect of retinoic acid and calcium ionophore A23187 on differentiation, c-myc expression, and membrane tyrosine kinase activity in human promyelocytic leukemia cell line HL-60.
Chapekar MS; Hartman KD; Knode MC; Glazer RI
Mol Pharmacol; 1987 Feb; 31(2):140-5. PubMed ID: 3100942
[TBL] [Abstract][Full Text] [Related]
35. The effects of combinations of the recombinant growth factors GM-CSF, G-CSF, IL-3, and CSF-1 on leukemic blast cells in suspension culture.
Miyauchi J; Kelleher CA; Wong GG; Yang YC; Clark SC; Minkin S; Minden MD; McCulloch EA
Leukemia; 1988 Jun; 2(6):382-7. PubMed ID: 2453760
[TBL] [Abstract][Full Text] [Related]
36. Treatment of HL60 cells with various combinations of retinoids and 1 alpha,25 dihydroxyvitamin D3 results in differentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis.
Bunce CM; Wallington LA; Harrison P; Williams GR; Brown G
Leukemia; 1995 Mar; 9(3):410-8. PubMed ID: 7885039
[TBL] [Abstract][Full Text] [Related]
37. Effects of transforming growth factor beta, tumor necrosis factor alpha, interferon gamma and LIF-HILDA on the proliferation of acute myeloid leukemia cells.
Kerangueven F; Sempere C; Tabilio A; Mannoni P
Eur Cytokine Netw; 1990; 1(2):99-107. PubMed ID: 2129395
[TBL] [Abstract][Full Text] [Related]
38. Effects of recombinant human tumor necrosis factor on the self-renewal capacity of leukemia blast progenitors in acute myeloblastic leukemia.
Nagata K; Tohda S; Suzuki T; Nara N
Leukemia; 1989 Sep; 3(9):626-30. PubMed ID: 2761317
[TBL] [Abstract][Full Text] [Related]
39. Retinoic acid cooperates with tumor necrosis factor and immune interferon in inducing differentiation and growth inhibition of the human promyelocytic leukemic cell line HL-60.
Trinchieri G; Rosen M; Perussia B
Blood; 1987 Apr; 69(4):1218-24. PubMed ID: 3103717
[TBL] [Abstract][Full Text] [Related]
40. In vitro action of tumor necrosis factor on myeloid leukemia cells.
Munker R; Koeffler P
Blood; 1987 Apr; 69(4):1102-8. PubMed ID: 2435341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
